Bloomberg Law
Feb. 21, 2023, 6:43 PM

Lilly Says Shortage Over for Diabetes Drug Taken for Weight Loss

Emma Court
Emma Court
Bloomberg News
Nacha Cattan
Nacha Cattan
Bloomberg News

Eli Lilly & Cosaid on Tuesday that all doses of its new diabetes drug Mounjaro are now available after social-media enthusiasm about the drug’s weight-loss benefits sparked a two-month-long shortage.

“Lilly is shipping all six doses of Mounjaro on an ongoing basis,” with no wholesale backorders, a spokeswoman said. But because the drug is still new and facing “dynamic demand, some pharmacies may experience an intermittent delay in receiving product from time to time.”

Mounjaro, also known as tirzepatide, was approved in the US last May to help people with type 2 diabetes control their blood sugar levels. ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.